Publications by authors named "Ingo Runnebaum"

Claim this Profile
R
Risk for non-sentinel metastases in the contralateral groin in patients with a unilateral positive sentinel lymph node in primary vulvar cancer- a subgroup analysis of the AGO-VOP.2 QS Vulva Study.
Anna Jaeger, Monika Hampl, Katharina Prieske, Christine Eulenburg, Juliane Reichenbach, Ingo Runnebaum

Gynecol Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GWAS meta-analysis identifies five susceptibility loci for endometrial cancer.
Dhanya Ramachandran, Xuemin Wang, Triin Laisk, Ying Zheng, Nathan Ingold, Ingo Runnebaum

EBioMedicine· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimally Invasive Surgery in Endometrial Cancer: Superior for Low-Risk and Comparable for High-Risk Cases in a 20-Year Cohort Study.
Valentina Auletta, Maya Ehab Hassan, Angela Kather, Nikolaus Gaßler, Davit Bokhua, Ingo B Runnebaum

Geburtshilfe Frauenheilkd· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intergroup statement: opportunistic salpingectomy-molecular pathology, clinical outcomes and implications for practice (German Ovarian Cancer Commission, the North-Eastern German Society of Gynecologic Oncology (NOGGO), AGO Austria and AGO Swiss).
Martin Pölcher, Pauline Wimberger, Ivo Meinhold-Heerlein, Ingo Runnebaum, Susanne Schüler-Toprak

Arch Gynecol Obstet· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for anastomotic leakage and its impact on survival outcomes in radical multivisceral surgery for advanced ovarian cancer: an AGO-OVAR.OP3/LION exploratory analysis.
Fabian Trillsch, Bastian Czogalla, Sven Mahner, Verena Loidl, Alexander Reuss, Ingo B Runnebaum

Int J Surg· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision surgery for endometriosis: preventing chronic pelvic pain in patients with higher pre-operative pain scores and in patients of advanced age.
Davit Bokhua, Angela Kather, Anna Kaufmann, Evangelia Polychronaki, Valentina Auletta, Ingo B Runnebaum

Arch Gynecol Obstet· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palbociclib plus letrozole in estrogen receptor-positive advanced/recurrent endometrial cancer: Double-blind placebo-controlled randomized phase II ENGOT-EN3/PALEO trial.
Mansoor R Mirza, Line Bjørge, Frederik Marmé, René DePont Christensen, Marta Gil-Martin, Ingo B Runnebaum

Gynecol Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian cancer prevention through opportunistic salpingectomy during abdominal surgeries: A cost-effectiveness modeling study.
Angela Kather, Habib Arefian, Claus Schneider, Michael Hartmann, Ingo B Runnebaum

PLoS Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reproductive outcomes after fertility-sparing surgery for cervical cancer - results of the multicenter FERTISS study.
Lenka Fricová, Stefan Kommoss, Giovanni Scambia, Gwenael Ferron, Roman Kocián, Ingo Runnebaum

Gynecol Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of GynTect Methylation Markers to Detect Recurrent Disease in Patients Treated for CIN3: A Proof-of-Concept Case-Control Study.
Heike Hoyer, Cornelia Scheungraber, Grit Mehlhorn, Ingke Hagemann, Sarah Scherbring, Ingo B Runnebaum

Cancers (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany.
Florian Schwarz, Habibollah Arefian, Michael Hartmann, Ingo Runnebaum

PLoS One· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
Domenica Lorusso, Marie-Ange Mouret-Reynier, Philipp Harter, Claire Cropet, Cristina Caballero, Ingo Runnebaum

Int J Gynecol Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of two genomic variants with HPV type-specific risk of cervical cancer.
Finja Seifert, Rieke Eisenblätter, Julia Beckmann, Peter Schürmann, Patricia Hanel, Ingo B Runnebaum

Tumour Virus Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant capecitabine versus nihil in older patients with node-positive/high-risk node-negative early breast cancer receiving ibandronate - The ICE randomized clinical trial.
Marcus Schmidt, Ulrike Nitz, Toralf Reimer, Sabine Schmatloch, Heiko Graf, Ingo Runnebaum

Eur J Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary prevention of ovarian cancer by salpingectomy: that's one small step for a surgeon, one giant leap for patients.
Ingo B Runnebaum, Angela Kather

J Cancer Res Clin Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022) - Part 2 with Recommendations on the Therapy of Precancerous Lesions and Early-stage Endometrial Cancer, Surgical Therapy, Radiotherapy and Drug-based Therapy, Follow-up Care, Recurrence and Metastases, Psycho-oncological Care, Palliative Care, Patient Education, and Rehabilitative and Physiotherapeutic Care.
Günter Emons, Eric Steiner, Dirk Vordermark, Christoph Uleer, Kerstin Paradies, Ingo Runnebaum

Geburtshilfe Frauenheilkd· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022). Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer, Geriatric Assessment and Supply Structures.
Günter Emons, Eric Steiner, Dirk Vordermark, Christoph Uleer, Kerstin Paradies, Ingo Runnebaum

Geburtshilfe Frauenheilkd· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of risk factors for recurrence in cervical cancer patients after fertility-sparing treatment: The FERTIlity Sparing Surgery retrospective multicenter study.
Jiri Slama, Ingo Bernard Runnebaum, Giovanni Scambia, Martina Aida Angeles, Kiarash Bahrehmand

Am J Obstet Gynecol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robotic-assisted Gynecological Surgery in Older Patients - a Comparative Cohort Study of Perioperative Outcomes.
Anke R Mothes, Angela Kather, Irina Cepraga, Anke Esber, Anja Kwetkat, Ingo B Runnebaum

Geburtshilfe Frauenheilkd· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, Characterization and Biological Investigation of the Platinum(IV) Tolfenamato Prodrug-Resolving Cisplatin-Resistance in Ovarian Carcinoma Cell Lines.
Marie-Christin Barth, Norman Häfner, Ingo B Runnebaum, Wolfgang Weigand

Int J Mol Sci· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Native-tissue pelvic organ prolapse (POP) repair with perineorrhaphy for level III support results in reduced genital hiatus size and improved quality of life in sexually active and inactive patients.
Anke R Mothes, Isabel Raguse, Angela Kather, Ingo B Runnebaum

Eur J Obstet Gynecol Reprod Biol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial.
Eric Pujade-Lauraine, Jessica Brown, Alan Barnicle, Jonathan Wessen, Pierre Lao-Sirieix, Ingo B Runnebaum

JCO Precis Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany.
Florian Schwarz, Habibollah Arefian, Michael Hartmann, Ingo Runnebaum

PLoS One· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunistic Salpingectomy for the Primary Prevention of Ovarian Cancer.
Ingo B Runnebaum, Angela Kather, Jalid Sehouli

Dtsch Arztebl Int· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Nickel(II), Palladium(II), and Platinum(II) Complexes with , Bidendate Cinnamic Acid Ester Derivatives: An In Vitro Cytotoxic Comparison to Ruthenium(II) and Osmium(II) Analogues.
Jana Hildebrandt, Norman Häfner, Helmar Görls, Marie-Christin Barth, Matthias Dürst, Ingo B Runnebaum

Int J Mol Sci· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis